Corporate Development Director - Strategy / M&A / AI jobs in United States
cer-icon
Apply on Employer Site
company-logo

Guardant Health · 1 day ago

Corporate Development Director - Strategy / M&A / AI

Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. The Corporate Development Director will support all aspects of the Corporate Development function, leading transaction due diligence, developing business cases, and maintaining relationships with external partners to execute strategic acquisitions and investments.

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics
check
H1B Sponsor Likelynote

Responsibilities

Lead the transaction due diligence process, incorporating data analytics and intelligent automation to streamline evaluation and improve decision accuracy
Develop business cases supported by advanced market, valuation, and financial analytics, including scenario modeling and trend forecasting
Support the Company’s growth strategy through the identification, assessment, and execution of M&A, investments, and partnerships, guided by data-driven insights and predictive intelligence
Maintain and refine structured processes to identify and evaluate strategic opportunities across multiple business areas, integrating both quantitative and qualitative assessments
Collaborate with business leaders to identify and prioritize opportunities in a systematic and informed manner, ensuring alignment with each unit’s objectives and long-term plans
Build and maintain strong relationships across business units to sustain an ongoing flow of high-quality strategic ideas and partnership opportunities
Partner with business leaders before, during, and after M&A activity to ensure strategic fit, long-term value creation, and smooth post-deal integration
Support cross-functional teams in developing acquisition business cases and executing transactions, coordinating with Finance, Accounting, Legal, Tax, HR, and other departments to ensure seamless diligence and execution
Continuously enhance analytical capabilities, incorporating modern data platforms, automation, and AI-enabled tools to improve sourcing, valuation, and post-merger performance tracking

Qualification

Corporate DevelopmentM&A ExperienceData AnalyticsFinancial AnalyticsStrategic PlanningNegotiation SkillsCommunication SkillsProblem-Solving SkillsProject Management

Required

8+ years of experience in Corporate Development or M&A at a comparable healthcare company or Investment Bank
Demonstrated M&A partnering and equity investment experience, including negotiation, execution, and transaction closing
Intermediate or advanced understanding of the biotech, diagnostic, or medical device industry
Strong analytical and problem-solving skills, with experience using modern data analytics, automation, and AI-assisted decision tools to support strategy and valuation work
Ability to structure and manage complex projects and processes with multiple stakeholders at all levels, including Executive and senior leadership
Excellent communication and presentation skills, with the ability to convey data-driven insights clearly and persuasively
Ability to travel, both domestically and internationally, 10%–20% to conferences and meetings

Preferred

Undergraduate business degree, MBA, or PhD degree with a technical background in genomics, therapeutics, or oncology preferred
Experience in Product, R&D, or Marketing a plus

Company

Guardant Health

company-logo
Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

H1B Sponsorship

Guardant Health has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (38)
2024 (50)
2023 (40)
2022 (72)
2021 (57)
2020 (29)

Funding

Current Stage
Public Company
Total Funding
$2.53B
Key Investors
Baillie GiffordSoftBank Vision FundOrbiMed
2025-11-05Post Ipo Equity· $284.4M
2025-11-05Post Ipo Debt· $350M
2023-12-21Post Ipo Equity· $90.7M

Leadership Team

leader-logo
AmirAli Talasaz
Co-founder and Co-Chief Executive Officer
linkedin
leader-logo
Helmy Eltoukhy
Chairman and Co-Chief Executive Officer
linkedin
Company data provided by crunchbase